BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17917332)

  • 1. Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.
    Okada K; Tsuji S; Tanaka K
    Intern Med; 2007; 46(19):1671-2. PubMed ID: 17917332
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica.
    Viswanathan S; Wong AH; Quek AM; Yuki N
    J Neuroimmunol; 2015 May; 282():92-6. PubMed ID: 25903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
    Elsone L; Panicker J; Mutch K; Boggild M; Appleton R; Jacob A
    Mult Scler; 2014 Apr; 20(4):501-4. PubMed ID: 23986097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
    de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
    Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica.
    Warth A
    Med Hypotheses; 2009 Sep; 73(3):361-2. PubMed ID: 19398170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interesting PRESentation of NMO.
    Klenofsky B; Youn C; Walters H; Navis A; Boniece I
    Mult Scler Relat Disord; 2018 Oct; 25():163-164. PubMed ID: 30081316
    [No Abstract]   [Full Text] [Related]  

  • 7. No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia.
    Tanaka Y; Kimura K; Kawachi I; Inuzuka T
    Neurology; 2010 Nov; 75(19):1745-7. PubMed ID: 21060099
    [No Abstract]   [Full Text] [Related]  

  • 8. Subacute encephalopathy associated with aquaporin-4 autoantibodies: a report of 2 adult cases.
    Stübgen JP
    Clin Neurol Neurosurg; 2012 Sep; 114(7):1110-3. PubMed ID: 22316608
    [No Abstract]   [Full Text] [Related]  

  • 9. "Response to the commentary on "neuromyelitis optica: potential roles for intravenous immunoglobulin"".
    Wingerchuk DM
    J Clin Immunol; 2013 Feb; 33(2):308. PubMed ID: 23054343
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
    Masi G; Cioni C; Arrigucci U; Cerase A; Annunziata P
    Neurol Sci; 2015 Oct; 36(10):1925-7. PubMed ID: 26050233
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in Neuromyelitis Optica: Take Them to the Clinic.
    Levin MH
    J Neuroophthalmol; 2017 Sep; 37(3):300-302. PubMed ID: 28376022
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on neuromyelitis optica: potential roles for intravenous immunoglobulin.
    Bichuetti DB; de Oliveira EM
    J Clin Immunol; 2013 Feb; 33(2):307. PubMed ID: 23054342
    [No Abstract]   [Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
    Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of neuromyelitis optica during pregnancy--treatment options and literature review.
    Jurewicz A; Selmaj K
    Clin Neurol Neurosurg; 2015 Mar; 130():159-61. PubMed ID: 25621712
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of natalizumab to prevent relapses in neuromyelitis optica.
    Kleiter I; Hellwig K; Berthele A; Kümpfel T; Linker RA; Hartung HP; Paul F; Aktas O;
    Arch Neurol; 2012 Feb; 69(2):239-45. PubMed ID: 22332191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
    Daouda MT; Obenda NS; Assadeck H; Camara D; Djibo FH
    Pan Afr Med J; 2016; 24():230. PubMed ID: 27800085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
    Geis C
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):130-1. PubMed ID: 25546791
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromyelitis Optica and Herpes Simplex Virus 2: A Viral Trigger for Aquaporin-4 Autoimmunity?
    Marin Collazo IV; Howe CL; Lucchinetti CF; Tobin WO
    Neurologist; 2018 May; 23(3):92-93. PubMed ID: 29722742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
    Waters P; Jarius S; Littleton E; Leite MI; Jacob S; Gray B; Geraldes R; Vale T; Jacob A; Palace J; Maxwell S; Beeson D; Vincent A
    Arch Neurol; 2008 Jul; 65(7):913-9. PubMed ID: 18625857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromyelitis optica and anti-aquaporin 4 antibody].
    Tanaka K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():265-70. PubMed ID: 26480711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.